 X4 Pharmaceuticals, Inc. NASDAQ:XFOR Q3 2022 Results Conference Call November 3, 2022 8:30 AM ET Company Participants Dan Ferry - LifeSci Advisors Paula Ragan - Chief Executive Officer Diego Cadavid - Chief Medical Officer Mark Baldry - Chief Commercial Officer Murray Stewart - Interim Chief Medical Officer Conference Call Participants Stephen Willey - Stifel Eva Privitera - Cowen Mayank Mamtani - B. Riley Securities Trevor Allred - Oppenheimer Swayampakula Ramakanth - H.C. 